Loading…

to bookmark your favorites and sync them to your phone or calendar.
arrow_back View All Dates
Thursday, January 23
 

9:25am EST

Opening Remarks
Thursday January 23, 2025 9:25am - 9:30am EST
Virtual
Speakers
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Thursday January 23, 2025 9:25am - 9:30am EST
Virtual

9:30am EST

Executive Interview: Victor Bulto, President, Novartis US
Thursday January 23, 2025 9:30am - 9:50am EST
Virtual
Moderators
avatar for Angus Liu

Angus Liu

Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a... Read More →
Speakers
avatar for Victor Bulto

Victor Bulto

President, US, Novartis
As President of the US unit for Novartis, Victor Bulto is pursuing a bold strategy to reimagine medicine and deliver on the company’s responsibility to unlock the potential for helping patients in the world’s largest healthcare market.Victor is driven by the pressing need to translate... Read More →
Thursday January 23, 2025 9:30am - 9:50am EST
Virtual
  Executive Interview

9:50am EST

Accelerating Pharmaceutical Processing Innovation Through Artificial Intelligence
Thursday January 23, 2025 9:50am - 10:10am EST
Virtual
With innovation in new modalities driving increased complexity in the pharmaceutical pipeline, there is increasingly urgent need to deliver speed, quality, cost-efficiency and improved environmental footprint in pharmaceutical manufacturing. CDMOs are innovating across a number of areas to deliver this transformation – including by employing artificial intelligence, bringing tangible use cases to a promising technology.

In this session, Mike Riley, CEO of Veranova and David Shrier, CEO and Co-Founder of Phorum AI, will discuss a novel collaboration between their companies and will discuss how innovations in AI can unlock the potential of great scientific teams to create exponential improvements - 10x or even 100x - in the efficiency of how pharmaceuticals are produced.
Speakers
avatar for David Shrier

David Shrier

Co-Founder & CEO, Phorum.AI
David Shrier is a serial entrepreneur and globally renowned advisor on digital acceleration. He has extensive technology innovation experience, having led $11 billion of growth initiatives and taken a company public on the NYSE. He runs venture studio Visionary Future, where he has... Read More →
avatar for Mike Riley

Mike Riley

CEO, Veranova
Mike Riley joined Veranova as Chief Executive Officer in May 2023. Mike has over 25 years of professional experience, the majority of which has been spent in the pharmaceutical contract development and manufacturing (CDMO) industry. Prior to joining Veranova, he spent 19 years at... Read More →
Thursday January 23, 2025 9:50am - 10:10am EST
Virtual
  Keynote

10:10am EST

Panel: Our AI future: A Sector-by-Sector Breakdown
Thursday January 23, 2025 10:10am - 10:50am EST
Virtual
As AI and machine learning continue to reshape biotech, medtech, and pharma, this panel will explore the latest trends, challenges, and opportunities for AI-driven advancements across these sectors. Experts will take an in-depth look at how AI is streamlining processes—from drug discovery to medical device development—and share real-world examples of its impact on patient care.
Moderators
avatar for Zoey Becker

Zoey Becker

Staff Writer, Fierce Pharma
Zoey Becker is a staff writer for Fierce Pharma. She joined the Fierce team in 2022 after interning at the Cincinnati Herald. Zoey is a graduate of Miami University, where she earned a degree in journalism as well as sociology. She currently resides in Chicago with her two goldfi... Read More →
Speakers
avatar for Sai Jasti

Sai Jasti

Head of Data Science & Artificial Intelligence, Bayer Pharmaceuticals R&D
Sai Jasti is Head of Data Science and AI for Bayer Pharma R&D. In this capacity, Sai is responsible for driving Digital, Data and Analytics for Pharma R&D. He is passionate about helping scientists discover transformative medicines faster and driving innovation using Machine learning... Read More →
avatar for Dr. Maria Luisa Pineda

Dr. Maria Luisa Pineda

Envisagenics, CEO and Co-Founder
Dr. Maria Luisa Pineda is the CEO and co-founder of Envisagenics. Dr. Pineda embarked on her career in STEM as a high school Intel International Science Fair winner in Miami after immigrating from Colombia in 2001. She received her doctorate from Cold Spring Harbor Laboratory School... Read More →
avatar for Lars Fogh Iversen, PhD

Lars Fogh Iversen, PhD

Senior Vice President, Digital Science & Innovation, Novo Nordisk A/S
Lars has held his current role since early 2022 and is responsible for accelerating the digital transformation of R&ED and driving scientific innovation beyond the limits of human cognition through the purpose of DSI.A long-time employee of Novo Nordisk, Lars has held a variety of... Read More →
avatar for Alexandra Goncalves

Alexandra Goncalves

VP & Head of Digital Health, Bristol Myers Squibb
Dr. Alexandra Goncalves is an internationally recognized academic cardiologist with a business acumen and serves as VP and Head of Digital Health at Bristol Meyers Squibb, leading DH business strategy and execution across all company portfolio, from clinical development to commercialization.Prior... Read More →
avatar for Najat Khan, PhD

Najat Khan, PhD

Chief R&D Officer and Chief Commercial Officer, Recursion
Dr. Najat Khan is Recursion’s Chief R&D and Chief Commercial Officer, adding deep expertise in pharmaceutical innovation and data science to its leadership team. Before joining Recursion, she served as the Chief Data Science Officer and Global Head of Strategy and Portfolio Organization... Read More →
Thursday January 23, 2025 10:10am - 10:50am EST
Virtual
  Panel

10:50am EST

Fireside Chat with Robert Zirkelbach, Chief Public Affairs Officer & Head of Strategic Initiatives, PhRMA
Thursday January 23, 2025 10:50am - 11:10am EST
Virtual
Moderators
avatar for Rebecca Willumson

Rebecca Willumson

SVP & Publisher, Fierce Life Sciences and Healthcare
Rebecca Willumson is the Senior Vice President of Questex's Life Sciences and Healthcare media divisions and the Publisher of FierceBiotech, FiercePharma and FierceHealthcare. She is responsible for overseeing the sales, editorial, and operations functions of the group’s digital... Read More →
Speakers
avatar for Robert Zirkelbach

Robert Zirkelbach

Chief Public Affairs Officer & Head of Strategic Initiatives, Pharmaceutical Research and Manufacturers of America (PhRMA)
Robert Zirkelbach is Chief Public Affairs Officer & Head of Strategic Initiatives at the Pharmaceutical Research and Manufacturers of America (PhRMA). In this role, Mr. Zirkelbach oversees the organization’s media, advertising and executive communications efforts, along with message... Read More →
Thursday January 23, 2025 10:50am - 11:10am EST
Virtual
  Presentation

11:10am EST

Executive Interview: Nelson Ambrogio, President of Radiology, Bayer Pharmaceuticals
Thursday January 23, 2025 11:10am - 11:30am EST
Virtual
Moderators
avatar for Fraiser Kansteiner

Fraiser Kansteiner

Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →
Speakers
avatar for Nelson Ambrogio

Nelson Ambrogio

President of Radiology, Bayer Pharmaceuticals
Nelson Ambrogio, President Radiology at Bayer, is a global healthcare leader with a career spanning more than 25 years with Bayer. Before joining Radiology in the beginning of 2024, he has been leading the Oncology Franchise for Bayer Pharmaceuticals in the United States, overseeing... Read More →
Thursday January 23, 2025 11:10am - 11:30am EST
Virtual
  Executive Interview

11:30am EST

The CRDMO Advantage
Thursday January 23, 2025 11:30am - 11:45am EST
Virtual
Dr. Armin Spura, CEO of BioDuro, talks to Expert Insights' Dr. Kurt Nielsen on how BioDuro's new integrated global CRO + CDMO model can accelerate translational science and the path from discovery to First-in-Human trials.
Moderators
avatar for Kurt Nielsen, Ph.D.

Kurt Nielsen, Ph.D.

Managing Partner, Expert Insights Consulting
Dr. Kurt Nielsen, a veteran industry executive and currently a Managing Partner at Expert Insights Consulting, a top advisory firm for Pharma Services firms and investors, and an Orientation Marketing strategic partner. Kurt has previously served in a variety of product development... Read More →
Speakers
avatar for Armin Spura, PhD

Armin Spura, PhD

Chief Executive Officer, BioDuro
Dr. Armin Spura joined BioDuro from Crown Bioscience, where he served as the Chief Executive Officer (CEO) for nearly five years, guiding the company through significant growth and strategic development. Throughout his career, Armin has held senior leadership positions at well-known... Read More →
Thursday January 23, 2025 11:30am - 11:45am EST
Virtual
  Executive Interview

11:45am EST

New Approaches for Bringing Advanced Biologics to Clinic Faster
Thursday January 23, 2025 11:45am - 12:00pm EST
Virtual
Darren Head, CEO and Chair of Bionova and Board member of Cellipont Bioservices, talks with Expert Insights' Dr. Kurt Nielsen on running two new CDMOs to bring advanced biologics to clinic faster.
Moderators
avatar for Kurt Nielsen, Ph.D.

Kurt Nielsen, Ph.D.

Managing Partner, Expert Insights Consulting
Dr. Kurt Nielsen, a veteran industry executive and currently a Managing Partner at Expert Insights Consulting, a top advisory firm for Pharma Services firms and investors, and an Orientation Marketing strategic partner. Kurt has previously served in a variety of product development... Read More →
Speakers
avatar for Darren Head

Darren Head

Chairman & President, Bionova Scientific
Darren Head is Chairman & President of Bionova Scientific. He also served as Chairman of Bionova’s Board of Directors from 2019 until the company was acquired by Asahi Kasei in 2022. Darren also serves as CEO of Cellipont Bioservices, a cell therapy CDMO based in the San Diego area.Prior... Read More →
Thursday January 23, 2025 11:45am - 12:00pm EST
Virtual
  Executive Interview

12:00pm EST

Scaling Complex Orals to Launch
Thursday January 23, 2025 12:00pm - 12:15pm EST
Virtual
Dr. Dan Smithey, CEO of Serán Bioscience, talks with Expert Insights' Dr. Kurt Nielsen about solving the most complex oral drug development and manufacturing challenges with innovative approaches and new technologies.
Moderators
avatar for Kurt Nielsen, Ph.D.

Kurt Nielsen, Ph.D.

Managing Partner, Expert Insights Consulting
Dr. Kurt Nielsen, a veteran industry executive and currently a Managing Partner at Expert Insights Consulting, a top advisory firm for Pharma Services firms and investors, and an Orientation Marketing strategic partner. Kurt has previously served in a variety of product development... Read More →
Speakers
avatar for Dr. Dan Smithey

Dr. Dan Smithey

President, CEO and Co-founder, Serán BioScience
Dr. Smithey is the President, CEO and Co-founder of Serán BioScience.  Over his 30-year career, he has led multiple research and development projects in a broad range of therapeutic areas.   His work has led to the successful development of several novel medicines, including Tucatinib... Read More →
Thursday January 23, 2025 12:00pm - 12:15pm EST
Virtual
  Executive Interview

12:15pm EST

Panel: Global Clinical Trials: Overcoming Barriers and Seizing Opportunities in an International Landscape
Thursday January 23, 2025 12:15pm - 1:05pm EST
Virtual
As clinical trials expand across borders, sponsors face unique challenges that can slow progress and increase complexity. This panel will dive into the key hurdles holding sponsors back, from navigating varying regulatory requirements to overcoming cultural and language barriers. Industry experts will explore strategies to streamline regulatory approvals, improve trial efficiency across diverse regions, and leverage cultural insights to enhance patient recruitment and retention. Join us for a deep dive into the opportunities and solutions driving the future of international clinical trials.
Moderators
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Speakers
avatar for Eric A. Hughes, MD, PhD

Eric A. Hughes, MD, PhD

Executive Vice President of Global R&D, Chief Medical Officer, Teva Pharmaceuticals
Eric A. Hughes, MD, PhD, is Executive Vice President, Global R&D and Chief Medical Officer at Teva, overseeing a global organization responsible for the discovery, development, registration, medical affairs and patient safety activities for Teva’s generics, biosimilar and innovative... Read More →
avatar for Janet Hammond, MD, PhD

Janet Hammond, MD, PhD

Chief Development Officer, Atea Pharmaceuticals
Janet is an expert in virology with a proven track record in antiviral therapeutic drug discovery and development. Janet has more than 20 years of broad and deep pharmaceutical and biopharmaceutical experience including clinical development program leadership and responsibilities... Read More →
avatar for Irfan Qureshi

Irfan Qureshi

Chief Medical Officer, Biohaven, Ltd
Irfan Qureshi, M.D., Chief Medical Officer, Biohaven (NYSE: BHVN) is a Board-certified neurologist with more than 20 years of experience in industry, academia, and patient care.Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing... Read More →
avatar for Judith Ng-Cashin, M.D.

Judith Ng-Cashin, M.D.

Chief Medical Officer, Novotech
Judith Ng-Cashin, M.D. joined Novotech in 2023 as its Chief Medical Officer. With a rich background encompassing over two decades in the international pharmaceutical, biotech, and CRO sectors, Dr. Ng-Cashin plays a pivotal role in shaping Novotech's global multi-regional later-phase... Read More →
avatar for Keiko Oishi

Keiko Oishi

President & COO, CMIC HOLDINGS Co., Ltd.
Thursday January 23, 2025 12:15pm - 1:05pm EST
Virtual
  Panel

1:05pm EST

Executive Interview: Keiko Oishi, President & COO, CMIC Holdings Co., Ltd.
Thursday January 23, 2025 1:05pm - 1:25pm EST
Hyatt Regency San Francisco
Moderators
avatar for Angus Liu

Angus Liu

Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a... Read More →
Speakers
avatar for Keiko Oishi

Keiko Oishi

President & COO, CMIC HOLDINGS Co., Ltd.
Thursday January 23, 2025 1:05pm - 1:25pm EST
Hyatt Regency San Francisco
  Executive Interview

1:25pm EST

Energizer Break
Thursday January 23, 2025 1:25pm - 1:40pm EST
Virtual
Thursday January 23, 2025 1:25pm - 1:40pm EST
Virtual

1:40pm EST

Panel: Pharma’s Financial Landscape: Revenue Trends, M&A Strategies, and Patent Expirations
Thursday January 23, 2025 1:40pm - 2:20pm EST
Virtual
With some of the industry’s top drugs moving toward patent cliffs later this decade, Big Pharma dealmakers have remained active despite economic uncertainties. The 2024 buyouts of Catalent, Alpine Immune Sciences and CymaBay Therapeutics—among others—showed that drugmakers were willing to strike deals for the right assets at the right prices. As the industry navigates the Inflation Reduction Act and other factors, biopharma leaders and venture capitalists on this panel will share their expectations for the year ahead.
Moderators
avatar for Fraiser Kansteiner

Fraiser Kansteiner

Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →
Speakers
avatar for Adam Pearson

Adam Pearson

Chief Strategy Officer, Astellas
As Chief Strategy Officer of Astellas Pharma, Adam Pearson plays a pivotal role in shaping the company’s corporate strategy, spearheading initiatives in business planning, the development and execution of Primary Focus strategies, business partnerships, Rx+ business creation, Patient... Read More →
avatar for Greg Graves

Greg Graves

Senior Partner, McKinsey & Company
Greg is a senior partner in McKinsey’s Life Sciences Practice, where he leads the practice’s strategy and corporate finance work. Greg focuses on defining winning corporate strategies in the face of industry disruption and market uncertainties. He works with companies across the... Read More →
avatar for Christine (Chris) Fox

Christine (Chris) Fox

Executive Vice President, U.S. Commercial, Teva Pharmaceuticals
Christine (Chris) Fox was appointed Executive Vice President, U.S. Commercial on November 20, 2023, leading all commercial activities for Teva in the U.S., including Teva’s generics, biosimilars and innovative medicines business. Chris brings more than 30 years of healthcare industry... Read More →
avatar for Jeb Keiper

Jeb Keiper

CEO & President, Nimbus Therapeutics, LLC
Jeb Keiper, MS, MBA, is CEO and president of Nimbus Therapeutics, LLC, a Boston-based biotechnology company focused on developing breakthrough medicines for patients through precision small molecule design. Jeb has overseen the discovery and development of multiple programs into clinical... Read More →
avatar for Anis Ha

Anis Ha

SVP, Deputy General Counsel Transactions and Contracting, Eli Lilly and Company
Anis Ha serves as the Senior Vice President / Deputy General Counsel of Transactions and Contracting at Eli Lilly and Company. Anis is a broadly experienced executive with global pharmaceutical, biotechnology, and law firm experience. In his current role at Eli Lilly, Anis leads a... Read More →
Thursday January 23, 2025 1:40pm - 2:20pm EST
Virtual
  Panel

2:20pm EST

Innovative Risk-Sharing Models for Biotech Success
Thursday January 23, 2025 2:20pm - 2:40pm EST
Virtual
Explore practical and flexible approaches to clinical trial partnerships, focusing on risk-sharing models that reduce financial burdens while fostering collaboration and commercial success.

Key Highlights:
  • Performance-Based Models: Share financial risks with clear goals and incentives for strategic alignment.
  •  Revenue Sharing for Biotech: Support smaller firms and innovative therapies with shared financial burdens and future revenue potential.
  •  Hybrid Approaches: Combine milestone-based payments with revenue-sharing elements to balance commitment and flexibility.

Speakers
avatar for John Murray

John Murray

VP Global Business Development & Country Head UK, SanaClis
John Murray leverages his profound experience within the drug development sphere across multiple disciplines, from clinical operations, supply chain, sourcing and risk mitigation co-investment. John is brokering new strategic partnerships and developing existing collaborations between... Read More →
Thursday January 23, 2025 2:20pm - 2:40pm EST
Virtual
  Presentation

2:40pm EST

Fireside Chat: Tolga Tanguler, EVP and Chief Commercial Officer, Alnylam
Thursday January 23, 2025 2:40pm - 3:00pm EST
Virtual
Moderators
avatar for Angus Liu

Angus Liu

Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a... Read More →
Speakers
avatar for Tolga Tanguler

Tolga Tanguler

EVP and Chief Commercial Officer, Alnylam
Tolga Tanguler joined Alnylam in January 2021 as Executive Vice President and Chief Commercial Officer with more than 20 years of experience in the global biopharmaceutical industry. At Alnylam, Tolga plays a pivotal role in scaling the company on a global stage, having expanded its... Read More →
Thursday January 23, 2025 2:40pm - 3:00pm EST
Virtual
  Keynote

3:00pm EST

Partner Presentation by RxLogix
Thursday January 23, 2025 3:00pm - 3:20pm EST
Virtual
Speakers
avatar for Raj More

Raj More

Chief Architect & CEO, RxLogix Corporation
Raj started his career in PV/Drug Safety about 26 years ago at Relsys Internation, in Southern California. This is the company that built Argus Safety suite, and Raj was one of the key persons in building Relsys. Following the acquisition of Relsys by Oracle, Raj started RxLogix Corporation.As... Read More →
Thursday January 23, 2025 3:00pm - 3:20pm EST
Virtual
  Presentation

3:20pm EST

The Future of Oncology: Key Investment Areas and Advancements in Treatment Methodologies
Thursday January 23, 2025 3:20pm - 4:00pm EST
Virtual
ADCs, bispecifics and radiopharmaceuticals are making waves in oncology treatment. Practice-changing clinical data have spurred major investments and deals. At the same time, much-touted cell therapies have run into real-world issues such as capacity and infrastructure limitations. During this panel, we will explore what’s next for these trends as the industry continues its efforts to advance patient care.
Moderators
avatar for Angus Liu

Angus Liu

Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a... Read More →
Speakers
avatar for Bassil I. Dahiyat, Ph.D.

Bassil I. Dahiyat, Ph.D.

President & Chief Executive Officer, Xencor
Bassil Dahiyat has been Xencor’s president and chief executive officer since the Company’s incorporation in August 1997. He is the co-founder of Xencor and co-inventor of Xencor’s breakthrough XmAb® technology. He has led the Company in creating a diverse clinical-stage portfolio... Read More →
avatar for Puja Sapra

Puja Sapra

Senior Vice President, Biologics Engineering and Oncology Targeted Discovery, AstraZeneca
I serve as Vice President, Tumour Targeted Delivery, Early Oncology. In my current role, I lead the research group dedicated to the discovery and preclinical development of targeted cancer therapeutics and novel delivery mechanisms that selectively attack cancer cells while sparing... Read More →
avatar for Hesham Abdullah

Hesham Abdullah

Senior Vice President, Global Head Oncology, Research & Development, GSK
Hesham Abdullah is a seasoned physician-scientist who uniquely combines a clinician’s understanding of the impact cancer has on patients with deep expertise in identifying transformational opportunities to improve cancer treatment and care.As the head of GSK’s global oncology... Read More →
avatar for Teresa Bitetti

Teresa Bitetti

President of the Global Oncology Business Unit and a member of the Executive Team, Takeda
Teresa Bitetti is President of the Global Oncology Business Unit and a member of the Executive Team at Takeda, where she oversees a global portfolio of therapies targeting gastrointestinal, thoracic, and hematological cancers. In this role, Teresa leads all aspects of Takeda’s multi-billion-dollar... Read More →
avatar for Mai-Britt Zocca, Ph.D.

Mai-Britt Zocca, Ph.D.

Founder and Chief Executive Officer, IO Biotech
Dr. Zocca brings more than 20 years of experience in the biotechnology field and has founded and co-founded several biotech spinouts. Her focus on translational and clinical immune oncology has led to the development of important investigational immunotherapies for a variety of cancer... Read More →
Thursday January 23, 2025 3:20pm - 4:00pm EST
Virtual
  Panel
  • Qtag Featured

4:00pm EST

Closing Remarks
Thursday January 23, 2025 4:00pm - 4:05pm EST
Virtual
Speakers
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Thursday January 23, 2025 4:00pm - 4:05pm EST
Virtual
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.
Filtered by Date - 
Clear filter
Wednesday, January 22
Thursday, January 23
Friday, January 24
Hyatt Regency San Francisco
Virtual
  • Executive Interview
  • Keynote
  • Panel
  • Presentation